---
title: "Edaravone - Amyotrophic Lateral Sclerosis"
sidebar: mydoc_sidebar
permalink: db12243-mesh-d000690-1.html
toc: false 
---


Path ID: `DB12243_MESH_D000690_1`
{% include image.html url="images/db12243-mesh-d000690-1.png" file="db12243-mesh-d000690-1.png" alt="db12243-mesh-d000690-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C005435 | edaravone | Drug |
| GO:0019430 | removal of superoxide radicals | BiologicalProcess |
| CHEBI:63726 | neuroprotective agent | ChemicalSubstance |
| CHEBI:66980 | nootropic agent | ChemicalSubstance |
| MESH:D000690 | Amyotrophic lateral sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Edaravone | POSITIVELY REGULATES | Removal Of Superoxide Radicals |
| Edaravone | SUBCLASS OF | Neuroprotective Agent |
| Edaravone | SUBCLASS OF | Nootropic Agent |
| Removal Of Superoxide Radicals | NEGATIVELY CORRELATED WITH | Amyotrophic Lateral Sclerosis |
| Neuroprotective Agent | NEGATIVELY CORRELATED WITH | Amyotrophic Lateral Sclerosis |
| Nootropic Agent | NEGATIVELY CORRELATED WITH | Amyotrophic Lateral Sclerosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB12243](https://go.drugbank.com/drugs/DB12243)
  - [https://en.wikipedia.org/wiki/Edaravone#Pharmacology](https://en.wikipedia.org/wiki/Edaravone#Pharmacology)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/4021#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/4021#section=Mechanism-of-Action)
